Szajna et al.
produced a purple reaction mixture that was stirred at room
temperature for 1 h. An excess of Et2O (∼60 mL) was added, and
the solution was cooled at (∼-18 °C) overnight. A purple solid
that had deposited was carefully dried under vacuum in four separate
portions. The solid was then recrystallized from CH3CN/Et2O at
Ph)2TPA following synthetic methods identical to those described
for protio analogues.13
(6-Ph)2-d6-TPA. This was prepared in a manner similar to that
reported by Karlin and co-workers for d6-tris((2-pyridyl)methyl)-
amine.12 To solid (6-Ph)2TPA (250 mg, 0.576 mmol) in a round-
bottom flask was added CH3C(O)OD (25 mL, Aldrich, 98%). The
resulting solution was refluxed under nitrogen for 48 h. After
cooling to ambient temperature, 5 M NaOH (∼30 mL) and CH2-
Cl2 (∼45 mL) were added. The reaction mixture was then stirred
for an additional 3 h, at which point the organic layer was separated,
dried over sodium sulfate, and filtered, and the solvent was removed
under reduced pressure. This yielded a white powder in quantitative
yield that was used without further purification: 1H NMR (CD3-
CN, 400 MHz) δ 8.49 (d, J ) 4.8 Hz, 1H), 8.06-8.02 (m, 4H),
7.80-7.76 (m, 2H), 7.72-7.67 (m, 4H), 7.56 (d, J ) 7.6 Hz, 2H),
7.49-7.40 (m, 6H), 7.20-7.18 (m, 1H); 2H NMR (CD3CN, 61.43
MHz) δ 4.0 ppm; LREI-MS m/z (relative intensity), 449 ([M +
H]+, 100%).
room temperature, resulting in the deposition of red-purple batches
-1
of needle-type crystals (77 mg, 77%): UV-vis, nm (ꢀ, M
cm
-1) 385 (30), 531 (17), 853 (19); FTIR (KBr, cm-1) 3399 (νOH),
1100 (νClO4), 625 (νClO4); FAB-MS (CH3CN/NBA), m/z (relative
intensity), 447 ([M - ClO4 - H2O - CH3CN]+, 100%); µeff (302
K) ) 2.92 µB. Anal. Calcd for C20H25N5Cl2O9Ni: C, 39.67; H,
3.83; N, 11.57. Found: C, 39.32; H, 3.85; N, 11.56.
[(6-Ph2TPA)Ni-Cl(CH3CN)]ClO4 (4). To a solution of Ni-
(ClO4)2‚6H2O (40 mg, 0.11 mmol) in CH3CN was added a slurry
of 6-Ph2TPA (48 mg, 0.11 mmol) in CH3CN. The resulting mixture
was stirred for ∼1 h. To this solution was added a slurry of Me4-
NCl (12 mg, 0.11 mmol) in CH3CN, and the resulting solution was
stirred for 1 h. During this time, the color of the reaction mixture
changed from brown to bright green. The solvent was then removed
under reduced pressure, and the green residue was redissolved in
CH2Cl2, filtered through a glass wool/Celite plug, and evaporated
to dryness. Recrystallization from CH3CN/Et2O at ambient tem-
[((6-Ph)2-d6-TPA)Ni(CH3CN)(CH3OH)](ClO4)2 (1-d6), [((6-
Ph)2-d6-TPA)Ni(ONHC(O)CH3)]ClO4 (3-d6), and [((6-Ph)2-d6-
TPA)Ni-Cl(CH3CN)]ClO4 (4-d6) were prepared using (6-Ph)2-
d6-TPA following synthetic methods identical to those described
for protio analogues.13
perature yielded green crystals suitable for X-ray crystallography
-1
(82 mg, 73%): UV-vis, nm (ꢀ, M
cm-1) 370 (36), 598 (8),
(6-Ph)2-d2-TPA. The preparation of (6-Ph)2-d2-TPA followed a
synthetic route similar to that reported for 6-Ph2TPA except for an
initial step involving reduction of 6-phenyl-2-pyridinecarboxyal-
dehyde.13 Specifically, d1-6-phenyl-2-pyridinemethanol was pre-
pared via the reduction of 6-phenyl-2-pyridinecarboxyaldehyde (780
mg, 4.26 mmol) with LiAlD4 (250 mg, 5.96 mmol) in dry THF
(55 mL). The LiAlD4 was placed in a 500 mL round-bottom flask
in 40 mL of THF. To this solution was carefully added a THF (15
mL) solution of 6-phenyl-2-pyridinecarboxyaldehyde. Following
stirring of the resulting mixture for ∼15 min at ambient temperature,
D2O (∼10 mL) was added. The solution was then extracted with
CH2Cl2. The organic fractions were dried over Na2SO4 and filtered,
and the solvent was removed under reduced pressure, yielding a
yellow oil (640 mg, 88%): 1H NMR (CD3CN, 400 MHz) δ 8.09-
8.07 (m, 2H), 7.85-7.82 (m, 1H), 7.74 (d, J ) 7.7 Hz, 1H), 7.52-
7.40 (m, 3H), 7.35 (d, J ) 7.5 Hz, 1H), 4.69 (s, 1H). d1-2-
(Chloromethyl)-6-phenylpyridine hydrochloride was prepared from
treatment of d1-phenyl-2-pyridinemethanol with freshly distilled
SOCl2 (yield: 99%): 1H NMR (CD3CN, 400 MHz) δ 8.42-8.38
(m, 1H), 8.09-8.05 (m, 3H), 7.90 (d, J ) 7.8 Hz, 1H), 7.67-7.58
(m, 3H), 5.36 (s, 1H). N,N-Bis((6-(phenyl)-2-pyridyl)-d1-methyl)-
N-((2-pyridyl)methyl)amine ((6-Ph)2-d2-TPA) was generated via
treatment of 2 equiv of d1-2-(chloromethyl)-6-phenylpyridine
hydrochloride with 1 equiv of 2-pyridylmethylamine in CH3CN in
the presence of sodium carbonate and tetrabutylammonium bromide.
The product obtained from this reaction was isolated and purified
as previously described (yield: 35%):13 1H NMR (CD3CN, 400
MHz) δ 8.49 (dt, J1 ) 4.8 Hz, J2 ) 1.4 Hz, 1H), 8.07-8.04 (m,
4H), 7.80-7.77 (m, 2H), 7.72-7.68 (m, 4H), 7.55 (d, J ) 7.6 Hz,
1007 (8); FTIR (KBr, cm-1) 2319 (νCH3CN), 1094 (νClO4), 623
(νClO4); FAB-MS (CH3CN/NBA), m/z (relative intensity), 535 ([M
- ClO4 - CH3CN]+, 100%). Anal. Calcd for C32H29N5Cl2O5Ni:
C, 56.76; H, 4.32; N, 10.34. Found: C, 56.53; H, 4.16; N, 9.85.
6-(d5-Ph)2TPA. The preparation of 6-(d5-Ph)2TPA followed a
synthetic route similar to that reported for 6-Ph2TPA except using
appropriately deuterated precursors.13 d5-6-phenyl-2-pyridinecar-
boxyaldehyde was prepared from 6-bromopicolylaldehyde and d5-
PhB(OH)2 (Aldrich, 98%-d) following a method reported by Canary
and co-workers for the protio analogue (yield: 37%):19 1H NMR
(CD3CN, 400 MHz) δ 10.09 (d, J ) 0.7 Hz, 1H), 8.12 (dd, J1 )
7.9 Hz, J2 ) 1.3 Hz, 1H), 8.03 (td, J1 ) 7.7 Hz, J2 ) 0.8 Hz, 1H),
7.88 (dd, J1 ) 7.5 Hz, J2 ) 0.8 Hz, 1H). d5-6-Phenyl-2-
pyridinemethanol was prepared via the reduction of d5-6-phenyl-
2-pyridinecarboxyaldehyde with NaBH4 in methanol/water (yield:
72%):13 1H NMR (CD3CN, 400 MHz) δ 7.85-7.80 (m, 1H), 7.73
(d, J ) 7.9 Hz, 1H), 7.34 (d, J ) 7.6 Hz, 1H), 4.70 (d, J ) 5.3 Hz,
2H), 3.75 (t, J ) 5.6 Hz, 1H). The halide derivative d5-2-
(chloromethyl)-6-phenylpyridine hydrochloride was prepared from
treatment of d5-phenyl-2-pyridinemethanol with freshly distilled
SOCl2 (yield: 98%): 1H NMR (CD3CN, 400 MHz) δ 8.26-8.22
(m, 1H), 7.98 (d, J ) 8.0 Hz, 1H), 7.78 (d, J ) 7.8 Hz, 1H), 5.23
(s, 2H). Preparation of N,N-bis((6-(d5-phenyl)-2-pyridyl)methyl)-
N-((2-pyridyl)methyl)amine (6-(d5-Ph)2TPA) was achieved via
treatment of 2 equiv of d5-2-(chloromethyl)-6-phenylpyridine
hydrochloride with 1 equiv of 2-pyridylmethylamine in CH3CN in
the presence of sodium carbonate and tetrabutylammonium bromide.
The product obtained from this reaction was isolated and purified
as previously described (yield: 62%):13 1H NMR (CD3CN, 400
MHz) δ 8.49 (m, 1H), 7.80-7.76 (m, 2H), 7.72-7.68 (m, 4H),
2
2H), 7.49-7.40 (m, 6H), 3.99-3.93 (br, 4H); H NMR (CD3CN,
61.43 MHz) δ 4.0 ppm; LREI-MS m/z (relative intensity), 445 ([M
2
7.55 (d, J ) 7.5 Hz, 2H), 7.20-7.17 (m, 1H), 3.96 (s, 6H); H
+ H]+, 100%).
NMR (CD3CN, 61.43 MHz) δ 8.2, 8.1, 7.5 ppm; LREI-MS m/z
[((6-Ph)2-d2-TPA)Ni(CH3CN)(CH3OH)](ClO4)2 (1-d2), [((6-
Ph)2-d2-TPA)Ni(ONHC(O)CH3)]ClO4 (3-d2), and [((6-Ph)2-d2-
TPA)Ni-Cl(CH3CN)]ClO4 (4-d2) were prepared using (6-Ph)2TPA
following synthetic methods identical to those described for protio
analogues.13
(relative intensity), 453 ([M + H]+, 40%).
[((6-(d5-Ph))2TPA)Ni(CH3CN)(CH3OH)](ClO4)2 (1-d10), [((6-
(d5-Ph))2TPA)Ni(ONHC(O)CH3)]ClO4 (3-d10), and [((6-(d5-
Ph))2TPA)Ni-Cl(CH3CN)]ClO4 (4-d10) were prepared using 6-(d5-
(18) The X-ray structure of a very similar complex, [(TPA)Ni(CH3CH2-
CN)(H2O)](ClO4)2, has been reported. Ito, M.; Sakai, K.; Tsubomura,
T.; Takita, Y. Bull. Chem. Soc. Jpn. 1999, 72, 239-247.
(19) Chuang, C.-L.; Lim, K.; Chen, Q.; Zubieta, J.; Canary, J. W. Inorg.
Chem. 1995, 34, 2562-2568.
3990 Inorganic Chemistry, Vol. 43, No. 13, 2004